Michael S. Malamas

机构：Northeastern University, Beth Israel Deaconess Medical Center, Harvard University, Hadassah Medical Center, Drug Discovery Laboratory (Norway), Universidad del Noreste · ORCID：0000-0002-4785-7525

发表论文 113 篇 · 总被引 4445 次 · h-index 32

代表论文

• The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity (2021 · Neuropharmacology · 被引 27)
• Design and synthesis of cyanamides as potent and selective N-acylethanolamine acid amidase inhibitors (2019 · Bioorganic & Medicinal Chemistry · 被引 22)
• N ‐Acylethanolamine acid amidase (NAAA) is dysregulated in colorectal cancer patients and its inhibition reduces experimental cancer growth (2021 · British Journal of Pharmacology · 被引 21)
• Inhibition of triple negative breast cancer-associated inflammation, tumor growth and brain colonization by targeting monoacylglycerol lipase (2022 · Scientific Reports · 被引 20)
• Endocannabinoid metabolism and transport as targets to regulate intraocular pressure (2020 · Experimental Eye Research · 被引 19)
• N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice (2021 · Neurotherapeutics · 被引 11)